Addicted to Nicotine
A National Research Forum

[Also see the Program Agenda for additional information.
Many of the speaker's slides will be available for viewing online in the future.]

Section I: History and Pharmacology

Nicotine Delivery Systems
John Slade, M.D.
Robert Wood Johnson Medical School
University of Medicine and Dentistry of New Jersey

Pharmacology of Nicotine
Jack E. Henningfield, Ph.D.
Johns Hopkins School of Medicine & Pinney Associates

Section II: Nicotine-Individual Risk Factors for Initiation

Ethnicity, Gender and Risk Factors for Smoking Initiation
Robin Mermelstein, Ph.D.
Health Research and Policy Center
University of Illinois at Chicago

Child and Adolescent Psychopathology as Risk Factors for Tobacco Use
Robert J. McMahon, Ph.D.
Child Clinical Psychology Program
University of Washington

The Genetic Epidemiology of Smoking
Kenneth S. Kendler, M.D.
Medical College of Virginia
Virginia Commonwealth University

Nicotine Metabolism Variability and Nicotine Addiction
Karen Ahijevych, Ph.D.
College of Nursing
Ohio State University

A Common Genetic Defect in Nicotine Metabolism Decreases Smoking
Rachel Tyndale, Ph.D.
Department of Pharmacology
University of Toronto

Section III: Nicotine-Environmental Risk Factors for Initiation

Economics
Frank J. Chaloupka, Ph.D.
Department of Economics
University of Illinois at Chicago

Advertising and Promotion
John P. Pierce, Ph.D.
Cancer Prevention and Control Program
University of California at San Diego

Access to Tobacco
Nancy A. Rigotti, M.D.
Massachusetts General Hospital
Harvard Medical School

Effective Prevention Programs for Tobacco Use
Mary Ann Pentz, Ph.D.
Norris Cancer Center
University of Southern California

Section IV: Biology of Nicotine Addiction

Neuropharmacology and Biology of Neuronal Nicotinic Receptors
Kenneth S. Kellar, Ph.D.
Department of Pharmacology
Georgetown University School of Medicine

Molecular Biology and Knockouts of Nicotinic Receptors
Marina Picciotto, Ph.D.
Department of Psychiatry
Yale University School of Medicine

Brain Chemistry and Imaging
Nora D. Volkow, M.D.
Medical Department
Brookhaven National Laboratory

Nicotine Reinforcement in Animals and Humans
Kenneth A. Perkins, Ph.D.
Western Psychiatric Institute and Clinic
University of Pittsburgh Medical Center

Section V: Psychobiology of Nicotine Addiction

Behavior/Cognitive Effects of Smoking
Stephen Heishman, Ph.D.
Intramural Research Program
National Institute on Drug Abuse, NIH

Comorbidity and Smoking
John Hughes, M.D.
Department of Psychiatry, Psychology & Family Practice
University of Vermont

Individual Differences in Smoking and Nicotine Addiction
Saul Shiffman, Ph.D.
Department of Psychology
University of Pittsburgh

Section VI: Treatment of Nicotine Dependence

Psychological Interventions
Sharon M. Hall, Ph.D.
Department of Psychiatry
University of California at San Francisco

New Medications for Nicotine Dependence Treatment
Richard D. Hurt, M.D.
Nicotine Dependence Center
Mayo Clinic

Combined Treatments
Maxine L. Stitzer, Ph.D.
Bayview Medical Center
Johns Hopkins University School of Medicine

Primary Care Based Interventions
Judith K. Ockene, Ph.D., M.Ed.
Division of Preventive and Behavioral Medicine
University of Massachusetts Medical Center

Treatment of Special Populations
Dorothy Hatsukami, Ph.D.
Department of Psychiatry
University of Minnesota

Interventions for Treatment Resistant Smokers
Karl Olav Fagerstrom, Ph.D.
Fagerstrom Consulting